Translational Oncology Research Group

The Translational Oncology Research Group investigates how inflammation, immunity, and the tumor microenvironment influence cancer development, progression, and treatment response. Our work spans basic and translational science, clinical research, and clinical trials, with a particular interest in developing new strategies to improve outcomes for patients with primary and metastatic cancers. We bring together laboratory, clinical, and population-based approaches to understand the mechanisms that drive cancer progression and treatment resistance and to translate those discoveries into better therapies and patient care.

Learn More About Our Lab